Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.

MLA

Rebecca E Colman, et al. “Whole-Genome and Targeted Sequencing of Drug-Resistant Mycobacterium Tuberculosis on the ISeq100 and MiSeq: A Performance, Ease-of-Use, and Cost Evaluation.” PLoS Medicine, vol. 16, no. 4, Apr. 2019, p. e1002794. EBSCOhost, https://doi.org/10.1371/journal.pmed.1002794.

APA

Rebecca E Colman, Aurélien Mace, Marva Seifert, Jonathan Hetzel, Haifa Mshaiel, Anita Suresh, Darrin Lemmer, David M Engelthaler, Donald G Catanzaro, Amanda G Young, Claudia M Denkinger, & Timothy C Rodwell. (2019). Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation. PLoS Medicine, 16(4), e1002794. https://doi.org/10.1371/journal.pmed.1002794

Chicago

Rebecca E Colman, Aurélien Mace, Marva Seifert, Jonathan Hetzel, Haifa Mshaiel, Anita Suresh, Darrin Lemmer, et al. 2019. “Whole-Genome and Targeted Sequencing of Drug-Resistant Mycobacterium Tuberculosis on the ISeq100 and MiSeq: A Performance, Ease-of-Use, and Cost Evaluation.” PLoS Medicine 16 (4): e1002794. doi:10.1371/journal.pmed.1002794.